Brexit Bombshell: Turbulence Ahead for Pharma and for Europe

REFLECTOR | July 5, 2016

article image
A violent thunderstorm rolled across the skies of Brussels throughout the night of June 23, as the prospect of a British exit from the EU became a reality. But it was nothing compared to the turbulence that the outcome of the referendum is already unleashing on the UK, on the EU, and way beyond – including on the pharmaceutical sector.

Spotlight

Advantia Health

Advantia Health is an innovative fast growing healthcare delivery company, founded and led by a passionate group of entrepreneurs and backed by top tier healthcare investors. Sean Glass, Founder & CEO of Advantia Health, previously founded and grew a financial technology company to more than a billion dollar valuation. Advantia Health provides high quality, high value care using technology and highly efficient outpatient facilities. In a little over three years, the company has grown to serve more than 100,000 customers and is on a path to serving many more in the years to come. Advantia’s investors include Deerfield Management, Life Force Capital, and individuals with significant health care, technology, and finance expertise.

OTHER ARTICLES

Clinical Supply Availability & Speed to Study Start-Up

Article | March 26, 2020

If you’re part of a clinical study team racing a new product to commercialization, you likely live by these two simple rules: time is money, and the first one to market wins. But just because it’s simple doesn’t mean it’s easy. That ticking clock is background noise to the responsibilities of regulations, study protocols, supply chains, and patient recruitment — all the details that must be worked out before a study can even begin. The pressure is always there. The longer it takes for a study to start, the longer it takes to complete.

Read More

Pfizer Won’t Win the Coronavirus Pharma War

Article | March 26, 2020

Shares of Pfizer jumped more than 6% on Wednesday, after the company announced a plan to test some of its antiviral products as a potential treatment for the coronavirus from China. More than 35 million shares traded on the news — about 48% more than normal — as investors looked for any positive news from the pharma community after the recent selloff. So, does this mean that Pfizer stock is turning the corner?

Read More

Top Pharmaceutical Firms Urge FDA to Adopt Blockchain for Drug Tracking

Article | March 26, 2020

Leading market participants in the United States pharmaceutical industry, logistics firms, distributors and other stakeholders in the pharma supply chain have come together to publish a report buttressing the need for industry players to adopt blockchain for tracking prescription drugs, following the successful completion of a DLT pilot project with the Food and Drug Administration (FDA), according to reports on February 24, 2020. Though nascent, blockchain technology, the building blocks of Bitcoin (BTC) and other cryptocurrencies are fast gaining ground across various ecosystems, due to its immutability, security, privacy, and other intricate properties. In the latest development, 25 leading manufacturers of pharmaceutical products, logistics partners and other market participants in the pharma supply chain, have published a report that highlights the importance of blockchain technology in drug traceability.

Read More

How Pharma Companies Can Scale Up Their Knowledge Discovery with Semantic Similarity Search

Article | March 26, 2020

Pharma has deep roots in human history with centuries of folk pharmaceutical knowledge offering a hit-and-miss range of natural remedies. But the industry as we know it today actually emerged in the second half of the 19th century when the world’s first factory for the sole production of medicines was found. By the late 19th and early 20th century, some chemical companies had already begun using research labs to explore the medical applications for their products. Fast forward to today and the pharmaceutical sector is a global trillion-dollar industry. However, to ensure the safety and efficacy of drugs, the process of drug discovery and development is under extensive scrutiny and control on both national and global levels.

Read More

Spotlight

Advantia Health

Advantia Health is an innovative fast growing healthcare delivery company, founded and led by a passionate group of entrepreneurs and backed by top tier healthcare investors. Sean Glass, Founder & CEO of Advantia Health, previously founded and grew a financial technology company to more than a billion dollar valuation. Advantia Health provides high quality, high value care using technology and highly efficient outpatient facilities. In a little over three years, the company has grown to serve more than 100,000 customers and is on a path to serving many more in the years to come. Advantia’s investors include Deerfield Management, Life Force Capital, and individuals with significant health care, technology, and finance expertise.

Events